Romanian pharma maker works with three
Indian companies
Local pharmaceutical
manufacturer Antibiotice Iasi (ATB), owned by the Romanian state, will work
with three Indian companies to develop antiviral drugs for treating
tuberculosis and cancer, according to Indian newspaper The Economic Times,
reports local Ziarul Financiar.
Antibiotice Iasi will work
with the Indian company Aurobindo Pharma for the development of antiviral
drugs, with the Indian company Macleods Pharma for tuberculosis treatment
products and with the Indian company Cipla for oncology drugs, according to Mario
Cretu, counselor of the Romanian Health Minister, quoted by The Economic Times.
Cretu also said that
Romania will collaborate with India to purchase licenses to sell drugs in
Europe.
A Romanian delegation
headed by the Minister of Health Nicolae Banicioiu is currently visiting India.
No comments:
Post a Comment